Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Etripamil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA declines to approve Milestone's heart rhythm nasal spray
    FDA declines to approve Milestone's heart rhythm nasal spray

    29 Mar 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-milestone-pharmas-heart-rhythm-nasal-spray-2025-03-28/

    REUTERS
    29 Mar 2025
    Share Share
    FDA Issues Complete Response Letter for Etripamil for PSVT
    FDA Issues Complete Response Letter for Etripamil for PSVT

    28 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/28/3051260/0/en/FDA-Issues-Complete-Response-Letter-for-Etripamil-for-PSVT.html

    GLOBENEWSWIRE
    28 Mar 2025
    Share Share
    Milestone Pharmaceuticals to Present Etripamil Data at ACC
    Milestone Pharmaceuticals to Present Etripamil Data at ACC

    20 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/20/3046176/0/en/Milestone-Pharmaceuticals-to-Present-Clinical-Data-on-Etripamil-at-the-American-College-of-Cardiology.html

    GLOBENEWSWIRE
    20 Mar 2025
    Share Share
    Milestone Pharma Notice of Allowance on New Patent for Etripamil
    Milestone Pharma Notice of Allowance on New Patent for Etripamil

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/02/19/3028736/0/en/Milestone-Pharmaceuticals-Notice-of-Allowance-on-New-U-S-Patent-for-Etripamil.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Milestone Pharmaceuticals To Host Investor Event On Feb 25 In NYC
    Milestone Pharmaceuticals To Host Investor Event On Feb 25 In NYC

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016316/0/en/Milestone-Pharmaceuticals-Provides-2025-Corporate-Outlook-and-Will-Host-Investor-Event-on-February-25-in-NYC.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share
    Milestone Pharmaceuticals to Host Investor KOL Event
    Milestone Pharmaceuticals to Host Investor KOL Event

    24 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/24/2952137/0/en/Milestone-Pharmaceuticals-to-Host-Investor-KOL-Event.html

    GLOBENEWSWIRE
    24 Sep 2024
    Share Share